Process engineering of human pluripotent stem cells for clinical application.
Margarida Serra1, Catarina Brito, Cláudia Correia
1Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Av. da República, 2780-157 Oeiras, Portugal.
Trends in Biotechnology
|May 1, 2012
Summary
Large-scale production of human pluripotent stem cells (hPSCs) requires advanced bioprocessing. Optimizing environmental factors and using 3D culturing with bioreactors can improve hPSC quality for cell therapies.
Area of Science:
- Stem Cell Biology
- Biotechnology
- Regenerative Medicine
Background:
- Human pluripotent stem cells (hPSCs) show great promise for cell therapy.
- Clinical applications necessitate scalable, high-quality hPSC production and storage.
- Current methods face challenges in meeting clinical demands for quantity and quality.
Purpose of the Study:
- To review key principles in human pluripotent stem cell (hPSC) bioprocessing.
- To highlight strategies for enhancing hPSC production for clinical use.
- To discuss the role of environmental factors and novel culturing techniques.
Main Methods:
- Discussion of established and emerging bioprocessing principles for hPSCs.
- Analysis of environmental factor impacts on hPSC culture.
- Exploration of three-dimensional (3D) culturing and bioreactor integration.
Main Results:
- Bioprocessing strategies significantly influence hPSC culture outcomes.
- Controlled environmental factors are crucial for consistent hPSC quality.
- 3D culturing and bioreactors offer improved scalability and control.
Conclusions:
- Advances in hPSC bioprocessing are essential for therapeutic applications.
- Optimized production platforms will accelerate the clinical translation of hPSC therapies.
- Integrated bioprocessing knowledge supports the development of robust cell manufacturing.
More Related Videos
Related Concept Videos
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...